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Abstract
A functional comparison was made between the wild-
type bradykinin B2 receptor (B2wt) and the chimera
B2eGFP (enhanced green-fluorescent protein fused to the
C-terminus of B2wt), both stably expressed in HEK 293
cells. There was almost no difference in terms of ligand-
inducible receptor phosphorylation and internalization,
signal transduction (accumulation of inositol phosphates)
or expression and affinity. However, stimulation for up to
8 h with 10 mM bradykinin (BK) resulted in a strong
decrease in surface receptors (by 60% within 5 h) in
B2wt, but not in B2eGFP. When the expression levels of
both constructs where comparably reduced using a
weaker promoter, long-term stimulation resulted in a
reduction in surface receptors for B2wtlow to less than
20% within 1 h, whereas the chimera B2eGFPlow still dis-
played 50% binding activity after 2 h. A 1-h incubation
in the absence of BK resulted in a recovery of 60% of
the binding in B2wtlow after 1-h stimulation with BK, but
of only 20% after 7-h stimulation. In contrast, B2eGFPlow
levels were restored to more than 70%, even after 7-h
stimulation. These data indicate that although the fusion
of eGFP to B2wt does not affect its ligand-induced inter-
nalization, it strongly reduces the down-regulation, most
likely by promoting receptor recycling over degradation.
Keywords: bradykinin B2 receptor; endocytosis; G
protein-coupled receptor; green fluorescent protein.
Introduction
G protein-coupled receptors (GPCRs) form the largest
membrane-receptor group in the mammalian genome
(Fredriksson et al., 2003). More than 40% of all com-
mercially available drugs exert their effects via members
of this group. Therefore, strong efforts have been made
in academia and in pharmaceutical industry research to
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elucidate the mechanisms that regulate the functions of
these receptors, in particular the processes that are
involved in the activation or de- and resensitization of the
receptors (Pierce et al., 2002; Brink et al., 2004; Maxfield
and McGraw, 2004).
Our group focuses on the regulation and signaling of
the bradykinin B2 receptor (B2wt). This receptor belongs
to family A of the GPCRs (Hess et al., 1992), i.e., the
rhodopsin/b-adrenergic-like receptors, and transmits sig-
naling of the small extracellular peptides bradykinin and
kallidin (Leeb-Lundberg et al., 2005) to intracellular com-
partments. The effects of these hormones include pain
sensation, vascular permeability resulting in edema, and
vasodilatation (Proud, 1988; Regoli et al., 2001; Stewart,
2004).
After stimulation with an agonist, most GPCRs seques-
ter to intracellular compartments. One elegant tool widely
applied to investigate the localization and trafficking of
receptor proteins in a living cell is the expression of the
receptors as fusion proteins with green-fluorescent pro-
tein (GFP) or derivatives thereof (Kallal et al., 1998; Mil-
ligan, 1999; Houle and Marceau, 2003). Although widely
used, not many data are available that describe in detail
whether and how joining GFP to the C-terminus of a
GPCR influences its overall behavior.
Therefore, we set out to determine whether fusion to
enhanced GFP (eGFP) changes the characteristics of the
bradykinin B2 receptor with respect to receptor traffick-
ing, affinity shift and signal transduction. Moreover,
experimental conditions such as receptor expression lev-
els and short- or long-term stimulation where also inves-
tigated in detail. Taken together, the results indicate that
fusion of eGFP to the C-terminus of the bradykinin B2
receptor does not affect its ligand-induced internaliza-
tion, but strongly reduces receptor down-regulation,
most likely via enhancement of receptor recycling.
Results
To determine to what extent ligation of eGFP to B2wt
affects its characteristics, we investigated several para-
meters: ligand affinity at 48C and 378C, accumulation
of inositol phosphates (IPs), basal and ligand-inducible
phosphorylation and internalization, and receptor down-
regulation. As the eGFP was fused to the C-terminus of
B2wt, this C-terminus was the main candidate domain for
which function could be affected. Therefore, we also
compared both constructs (B2wt and B2eGFP) with the
B2 receptor truncation K315stop as a control. This
mutant is lacking the last 50 amino acids of the C-ter-
minus due to insertion of a stop codon after lysine 315
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Table 1 Binding and functional properties of various receptor constructs.
Receptor w3HxBK binding Inositol phosphate accumulation
construct
Bmaxa Kd (PAO/48C)b Kd(PAO/378C)b Basalc Maximum EC50d
(fmol/mg protein) (nM) (nM) (nM) effectc (nM) (nM)
B2wt 10.4 3.53"0.91 (5) 11.78"1.82 1.93"0.17 (7) 12.86"1.37 0.79"0.34 (4)
B2eGFP 9.3 4.48"0.95 (3) 10.38"0.08 1.71"0.16 (3) 15.38"2.72 1.26"0.87 (3)
B2wtlow 4.4 2.02"0.22 (5) 8.05"1.10 1.73"0.12 (5) 11.39"1.64 0.67"0.02 (3)
B2eGFPlow 4.0 ND ND ND ND ND
K315stop 1.5 3.79"0.22 (3) 4.65"0.60 1.56"0.16 (4) 7.86"1.69 13.10"2.75 (4)
aEstimated from at least three different clones in 24 wells after incubation with 200 ml of 10 nM w3HxBK on ice.
bThe dissociation constant Kd (mean"SEM) was determined in parallel at 48C and at 378C after pretreament of the cells with
phenylarsine oxide (PAO) as described in the materials and methods section.
cTotal inositol phosphate (IP) accumulation after 30-min incubation in buffer with inhibitors and 50 mM LiCl at 378C with
(maximal effect) and without (basal) 1 mM BK, expressed as the fold increase in initial total IP production (ts0 min). The results
represent the mean"SEM of the number of experiments (given in parentheses) performed in triplicate.
dCalculated from duplicate incubations with 10-11–10-5 M BK for 30 min at 378C in the presence of 50 mM LiCl. Results are
the mean"SEM of independent experiments (number indicated in parentheses). ND, not determined.
and can serve as an example for the characteristics of a
mutant with an extremely truncated C-terminus.
Fusion with eGFP does not affect receptor
expression or affinity
Tagging the C-terminus of the B2wt receptor with eGFP
apparently did not affect receptor expression, as B2wt
and B2eGFP with approximately 10 pmol/mg protein
were both similarly overexpressed (Table 1). The Flp-In
expression system uses the transient co-expression of a
recombinase to insert the gene of interest at a specific
site in the genome of a host cell line. Thus, the distinctly
lower expression level of truncation K315stop most likely
reflects differences in posttranscriptional or posttransla-
tional processes, such as trafficking and/or protein turn-
over, caused by the lack of the C-terminus that were
obviously not mimicked by the fusion of eGFP to the
receptor C-terminus.
When sequestration of B2wt is inhibited by preincu-
bation of the cells with phenylarsine oxide, it is possible
to determine the equilibrium binding constant (Kd) at 48C,
as well as at 378C (Faussner et al., 2004). B2wt showed
a shift to lower affinity when the temperature was
increased from 48C to 378C and vice versa. In contrast,
the mutant receptor K315stop did not exhibit significantly
lower affinity at 378C than at 48C, indicating that the C-
terminally truncated receptor is trapped in a conforma-
tion with higher affinity. However, it is not yet clear
whether this is an intrinsic property of the truncation
mutant or due to interactions with other intracellular pro-
teins that have been changed by the lack of the C-ter-
minus. The B2eGFP chimera, however, still displayed shift
behavior similar to the B2wt (Table 1), suggesting that
tagging with eGFP does not hamper the role that the C-
terminus plays in the affinity shift.
B2eGFP mediates release of total inositol phosphate
levels comparable to B2wt
When challenged with bradykinin (BK), B2wt and B2eGFP
induced an accumulation of total inositol phosphates that
was almost identical in terms of potency (EC50) and effi-
cacy (maximal effect). In contrast, the K315stop receptor
mutant exhibited a reduced maximal effect – probably
due to its lower expression level – and a more than 10-
fold shift of the EC50 to lower values (Table 1), indicating
that the C-terminus directly or indirectly plays a role in
the coupling of the receptor to G protein Gq/11. Again this
function was not affected by C-terminal fusion of the
receptor to eGFP.
B2wt and B2eGFP display equally fast internalization
As we have shown recently using high ligand concentra-
tions, the rate of w3HxBK uptake (ligand internalization)
decreases in cells overexpressing B2wt when too many
receptors are occupied (Faussner et al., 2003). Therefore,
we took care to apply a w3HxBK concentration below the
Kd value, at which the internalization rate is largely con-
centration-independent, even for high expression levels.
At these low concentrations, the decrease in surface
binding and the increase in internalized w3HxBK for the
chimeric construct B2eGFP were similar to the rates
observed for B2wt (Figure 1A, B). For both constructs,
more than 80% of total bound w3HxBK could be detected
inside the cells within 10 min (Figure 1C), indicating that
joining of the 27-kDa eGFP protein to the C-terminus of
B2wt does not affect the interaction of this domain with
the internalization machinery of the cell. Mutant receptor
K315stop, however, exhibited very little internalization,
not surpassing 20% after 30 min, thus confirming our
results obtained in Chinese hamster ovary cells (Fauss-
ner et al., 1998) and the general importance of this recep-
tor part for receptor internalization.
Phosphorylation patterns of B2wt and B2eGFP
reflect their agonist-inducible internalization
B2wt displayed distinct phosphorylation, even in the
absence of a stimulus (Figure 2), as previously reported
for HEK 293 cells and human fibroblasts (Blaukat et al.,
2001; Kalatskaya et al., 2004). When stimulated for 5 min
with a saturating concentration of 1 mM BK at 378C, B2wt
responded with a marked increase (2.5"0.06-fold over
basal, ns3) in phosphorylation. Interestingly, B2eGFP
exhibited even stronger basal phosphorylation, with
bands appearing in the region of 80–110 kDa, as could
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Figure 1 Internalization of w3HxBK by B2wt, chimera B2eGFP,
and truncation K315stop.
Monolayers of HEK 293 cells stably expressing B2wt were prein-
cubated with less than 1.5 nM w3HxBK for 90 min at 48C. The
internalization was initiated by warming the plates to 378C. At
the times indicated, internalization was stopped and surface-
bound and internalized w3HxBK were determined as described in
the materials and methods section. Results are given as the
mean"SD of triplicate determinations. A representative experi-
ment of three is shown for B2wt (A) and the chimera B2eGFP (B):
sur, surface-bound w3HxBK; int, internalized w3HxBK; tot, total
w3HxBK. (C) Internalization as a percentage of total binding (sur-
face boundqinternalized w3HxBK). All symbols show the
mean"SD for at least three experiments performed in triplicate.
Figure 2 Agonist-induced phosphorylation of B2wt and
B2eGFP.
HEK 293 cells expressing B2wt or B2eGFP were labeled for 12 h
with w32Pxorthophosphate before stimulation with 1 mM BK for
5 min. Cells were lysed and receptor proteins were solubilized,
precipitated, and visualized by autoradiography as described in
the materials and methods section. Molecular size markers are
indicated on the left. Mock-transfected HEK 293 cells were used
as control cells. The experiment shown was repeated three
times with similar results.
be expected for the larger chimera (Figure 2). Neverthe-
less, the fusion protein still responded to BK stimulation
with a significant increase in phosphorylation (1.3"0.03-
fold over basal, ns3). Mutant K315stop lost all phospho-
rylation sites, and therefore no basal or stimulated
phosphorylation could be expected (Blaukat et al., 2001).
Stability of BK in cell culture medium
To study B2wt down-regulation, it is necessary to stim-
ulate the receptor over a period of several hours with an
agonist. Bradykinin, however, is a very good substrate,
especially for metalloproteases (Dendorfer et al., 1997;
Stewart, 2004) found either on the cell membrane such
as neutral endopeptidase (NEP, neprilysin) or in serum
added to the cell culture medium (Bachvarov et al.,
2001). The addition of protease inhibitors, such as 1,10-
phenanthroline, to prevent proteolysis of the labeled or
unlabeled BK is tolerated by cells for only short incuba-
tion times for the binding or stimulation periods (Fauss-
ner et al., 2003, 2004). However, the cells do not tolerate
such additives for the longer periods necessary for
down-regulation experiments. To avoid long-term expo-
sure to these harmful protease inhibitors, we tested the
stability of BK at 378C in a cell culture medium supple-
mented with fetal calf serum (10% v/v) for which the pro-
teolytic activity was strongly reduced by incubation for
2 h at 608C. To determine the effectiveness of this pre-
treatment, intact BK (initially 10 mM) in the supplemented
medium was tested after various times for binding to the
receptor in a competition assay with w3HxBK. As the full
reduction in w3HxBK binding to B2wt-expressing control
cells in Figure 3 reveals, there was still a saturating
amount of BK left after 8 h when added to cell medium
supplemented with inactivated serum, and even after
24 h, binding of 2 nM w3HxBK could still be considerably
inhibited. In cell culture medium supplemented with nor-
mal fetal calf serum, however, there was not enough BK
left after 3 h to fully compete with 2 nM w3HxBK for binding
to the receptor. These data demonstrate that when higher
amounts ()1 mM) of BK are used, the proteolytic activity
of the cells themselves can be neglected over a period
of 24 h, as long as the proteolytic activity in the cell cul-
ture medium is strongly reduced by heat inactivation.
Importantly, the heat-inactivated fetal calf serum itself
had no specific effects on the cells, as no difference
regarding either phenotype or w3HxBK binding activity was
observed compared to cells incubated for 24 h with cell
culture medium supplemented with normal fetal calf
serum.
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Figure 3 Stability of BK in different cell culture media.
HEK 293 cells in 48-well plates were incubated with 10 mM BK
in 500 ml of medium with either inactivated (treated for 2 h at
608C) serum (d) or with fresh serum (s) for the times indicated.
Thereafter, binding of 2 nM w3HxBK to HEK 293 expressing B2wt
(48-well plates, 150 ml) was determined in a competition assay
after addition of 10 ml of the respective media as described in
the materials and methods section. Binding is expressed as a
percentage of binding in control cells that received 10 ml of
medium without the addition of 10 mM BK. Points represent the
mean"SD of three experiments performed in duplicate (d) or of
two experiments performed in triplicate (s).
Figure 4 Time curve for the effect of BK on surface binding.
HEK 293 cells stably expressing B2wt at a high level (B2wt,
10.4 pmol/mg protein) or at a lower level (B2wtlow, 4.4 pmol/mg
protein), chimera B2eGPF at a high level (B2eGFP, 10 pmol/mg
protein) or at a lower level (B2eGFPlow, 4 pmol/mg protein) or C-
terminally truncated receptor mutant K315stop at a level of
1.5 pmol/mg protein were incubated with 10 mM BK in cell cul-
ture medium containing 10% inactivated fetal calf serum. At the
times indicated, all bound and free unlabeled BK was removed
with an acetic acid solution and the remaining specific surface
binding was determined with 2 nM w3HxBK at 48C as described
in the materials and methods section. Symbols represent the
mean"SD for at least three experiments performed in duplicate
or triplicate.Highly expressed B2eGFP displays no down-
regulation
When monolayers of B2wt-expressing HEK 293 cells
were incubated in cell culture medium supplemented
with inactivated fetal calf serum for up to 24 h with 10 mM
BK, a clear decrease in surface binding could be ob-
served for B2wt, which after 5 h reached a plateau of
-40% of the control binding measured in unstimulated
cells (Figure 4). The rate of decrease strongly depended
on the expression level, as indicated by another HEK 293
clone (B2wtlow) expressing the same B2wt construct under
the control of the weaker promoter Pmin (Faussner et al.,
2004). The use of this weaker promoter resulted in dis-
tinctly lower expression, with 4.4 compared to 10.4 pmol/
mg protein of B2wt expression obtained under the control
of the standard CMV promoter (Table 1). The construct –
termed B2wtlow – responds to prolonged BK stimulation
with a reduction in surface binding of 90% within 2 h
(Figure 4), thus stressing the influence of the receptor
expression level on the outcome of a down-regulation
experiment.
When challenged with BK, the chimera B2eGFP
showed no loss of surface binding at all, even after 8 h
of stimulation with an initial concentration of 10 mM BK
(Figure 4). Only after longer incubation periods for up to
24 h could a decrease in binding be measured (data not
shown). As almost all cells expressing bradykinin B2
receptors and variants thereof responded to prolonged
exposure to BK with strong cell contraction and weak-
ened adherence to the cell culture plate, it is not clear
whether this apparent decrease in agonist binding should
be considered as receptor down-regulation or rather as
the result of general degeneration of the cells caused by
overstimulation.
To test whether the apparent lack of B2eGFP down-
regulation during an 8-h incubation time is absolute or in
part due to the strong receptor overexpression, we also
generated clones expressing the chimera B2eGFP at a
distinctly lower level (4 pmol/mg protein) under the con-
trol of the promoter Pmin (termed B2eGFPlow). In this case,
stimulation with BK resulted in reduced surface binding
resembling that of the highly expressed B2wt (Figure 4);
thus, it was much less pronounced than the reduction
observed for B2wtlow expressed at a comparable level.
These data indicate that fusion of eGFP to the C-termi-
nus of the bradykinin B2 receptor strongly reduces but
does not completely block its down-regulation.
Despite its low receptor expression, the truncation
mutant K315stop showed no decrease at all in agonist
binding even after 8 h of stimulation with BK, suggesting
that ligand-induced receptor down-regulation requires
either internalization of the receptor or at least (modifi-
cation of) specific sequences in the C-terminal receptor
domain as a first step.
Fusion to eGFP results in enhanced recycling of the
B2 receptor
The fast internalization of w3HxBK, but no (B2eGFP) or only
a slow decrease (B2eGFPlow) in the cell surface-receptor
number after stimulation suggests that there is significant
recycling of the B2eGFP chimera after internalization. In
addition, it is of interest to know whether the reduced
receptor number on the cell surface after long-term stim-
ulation constitutes true down-regulation, i.e., inactivation/
degradation of the sequestered receptors, or whether
they can reappear at the cell surface to a lesser degree
after removal of the stimulus.
Roscher et al. (1984) showed that after short stimula-
tion of 15 min with a saturating concentration of BK, a
recovery time of 1 h is enough to restore binding almost
completely in human fibroblasts. As this recovery was
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Figure 5 Receptor recovery in B2wtlow and B2eGFPlow.
HEK 293 cells stably expressing B2wtlow (A) or chimera B2eGPFlow
(B) were incubated for the times indicated with 10 mM BK in cell
culture medium containing 10% inactivated fetal calf serum
(FCS). The remaining surface binding was either determined
immediately (n,s) as described in the legend to Figure 4 or the
monolayers were washed and further incubated for 1 h at 378C
in medium with fresh FCS to promote degradation of residual
BK and allow receptor recycling back to the cell membrane,
before the remaining surface binding was determined as
described above (m, d). Symbols represent the mean"SD for
three experiments performed in duplicate.
unaffected by cycloheximide, it necessarily implied recy-
cling of the receptors. We tested, therefore, the capability
of the low-expressing cells to recover receptor binding
after incubation for 1 h in the absence of BK.
Stimulation of B2wtlow with a saturating concentration
of 10 mM BK resulted in a fast decrease in surface bind-
ing (Figure 5A; see also Figure 4). Although stimulation
for 1 h produced a decrease to-20% of the initial bind-
ing, subsequent incubation at 378C in the absence of BK
generated a recovery in binding to almost 60%, indicat-
ing that a greater proportion of the sequestered receptors
was not degraded after 1 h, but could be recycled back
to the cell surface. Stimulation with BK for more than 1 h
strongly diminished this capability to recover, implying
that degradation had overtaken recycling (Figure 5A). For
the chimera B2eGFPlow the situation was clearly different.
The reduction in cell surface receptor number caused by
stimulation with BK for up to 2 h (approx. 50%) could be
nearly completely restored by incubation for 1 h in the
absence of BK (Figure 5B), and even after a stimulation
period of 7 h almost 70% of the receptors reappeared
after 1 h without stimulus, suggesting that even during
prolonged stimulation most of the chimera continues to
recycle between the cell surface and intracellular com-
partments. This clearly indicates that the fusion of eGFP
to the receptor C-terminus strongly promotes recycling
of the receptor, thus overcoming its degradation. It also
explains the apparently poor sequestration, i.e., the
reduction in receptor number on the cell surface after
stimulation, unequivocally observed for the chimera (Fig-
ure 4).
Discussion
Many GPCRs respond to stimulation by an agonist with
sequestration of the receptor from the cell surface to
intracellular compartments such as early endosomes.
From there, they either return to the cell surface (re-
cycling) or end up in lysosomes and are degraded
(down-regulation). As this receptor endocytosis and its
regulation play a pivotal role in the control of cell respon-
siveness to extracellular stimuli, elucidation of the mech-
anisms involved is a main focus of ongoing research in
the GPCR field (Ferguson, 2001; Marchese et al., 2003).
One widely used tool is the generation of receptor chi-
meras with eGFP that allow the direct tracking of a
receptor within a living cell with the help of fluorescence
microscopy. For GPCRs, the fluorescent protein has
been exclusively joined to the intracellular C-terminus.
The current model of receptor internalization – resulting
predominantly from data obtained for the b2-adrenergic
receptor (Perry and Lefkowitz, 2002) – starts with the
phosphorylation of specific Ser/Thr-residues in the C-ter-
minus through the action of second-messenger activated
kinases and/or the more receptor-specific GRKs (G pro-
tein-coupled receptor kinases). Subsequently, adaptor
proteins such as arrestins bind to these phosphorylated
sequences and mediate the translocation of the receptor
to and its internalization through clathrin-coated pits
(Mousavi et al., 2004) or other less well-understood
mechanisms, such as pathways involving caveolae
(Haasemann et al., 1998; Roseberry and Hosey, 2001).
The almost complete absence of receptor internaliza-
tion observed in the B2 truncation mutant K315stop
(Faussner et al., 1998; Figure 1C) demonstrates the rel-
evance of the intact C-terminus for this function in B2wt.
It has also been shown for B2wt that the phosphorylation
of Ser/Thr residues is indispensable for fast sequestra-
tion (Blaukat et al., 2001). Deglycosylated B2wt has a
molecular mass of approximately 40 kDa and its C-ter-
minus consists of only approximately 60 amino acid res-
idues. For this reason it cannot be taken for granted that
tagging the C-terminus with a 27-kDa protein would not
interfere with its function, in particular with the receptor
trafficking that largely depends on this domain.
On first sight, B2eGFP displayed properties similar to
those of B2wt: it bound w3HxBK with the same affinity and
had a similar expression level. In addition, B2eGFP was
located almost exclusively at the membrane and was
found in intracellular vesicles of various sizes only after
stimulation with BK (data not shown here, but reported
by Kalatskaya et al., 2004), in full agreement with other
reports (Bachvarov et al., 2001; Sabourin et al., 2002;
Simaan et al., 2005). The fusion protein can interact nor-
mally with its cognate G proteins, as it exhibited a low
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level of basal signaling and IP accumulation could be
stimulated several-fold above this basal level. Moreover,
similar to B2wt, B2eGFP displayed a clear temperature-
dependent affinity shift, indicating proper interaction at
the plasma membrane with the cognate G protein and/
or other cytosolic proteins (Mitchell et al., 1998; Gether,
2000). Finally, the chimera B2eGFP displayed significant
ligand-inducible phosphorylation and fast ligand inter-
nalization comparable to that of B2wt. The properties of
the truncation receptor K315stop demonstrated that the
C-terminus plays an important role in all these processes,
as this mutant lacking the C-terminus displayed no affin-
ity shift, whereas its signaling exhibited a more than 10-
fold shift of EC50 to lower values for IP accumulation
(Table 1). This lower EC50 may also explain the apparently
strong reduction in maximal effect (by 70%) found for
similar truncation of the rat bradykinin B2 receptor, as a
low concentration of 10 nM BK was used to determine
the maximal effect (Prado et al., 1997).
The truncation mutant K315stop showed no decrease
in surface binding, even after prolonged stimulation with
BK, suggesting that ligand-induced receptor down-reg-
ulation requires either internalization of the receptor or
specific sequences and/or modification thereof in the C-
terminal receptor domain as a first step. This, and the
fact that internalization but not down-regulation remained
unchanged in the presence of eGFP, indicates that these
two processes are sequential and that they can be
uncoupled by fusion of the receptor to eGFP. Thus, these
data are in contrast to results obtained for the angioten-
sin AT1 receptor, for which down-regulation was reported
to be independent of ligand-inducible receptor endocy-
tosis (Modrall et al., 2001). Two AT1 truncation mutants,
comparable to K315stop, did not internalize, but could
nevertheless be down-regulated to 60% within 8 h, sim-
ilar to the wild type AT1 receptor. This may indicate
different regulation and trafficking of bradykinin B2 com-
pared to the angiotensin AT1 receptor.
The rate of decrease in surface binding of both B2wt
and the chimera B2eGFP is strongly dependent on
the expression levels. However, comparison of the con-
structs at two different expression levels clearly revealed
that fusion of eGFP to the receptor C-terminus strongly
reduced sequestration as an effect of long-term BK stim-
ulation, blocking it completely at the high expression lev-
el (10 pmol/mg protein) and strongly slowing it down at
the lower level (4 pmol/mg protein). As the internalization
rates of B2wt and B2eGFP were comparable, this sug-
gests the possibility that the B2eGFP chimera has either
a higher recycling rate than B2wt, or that it continues to
recycle, whereas B2wt is degraded on prolonged stimu-
lation. The results of the recovery experiment (Figure 5)
point to the latter possibility, because even after 7 h of
stimulation, most of the internalized B2eGFPlow receptor
could be restored to the cell surface, whereas this was
not the case for B2wtlow.
To identify the cause of the different behavior of B2wt
and the chimera B2eGFP, several possibilities have to be
taken into account. For example, our data demonstrate
that the chimera B2eGFP can interact properly with
kinases involved in receptor internalization, but owing to
the many more spots observed for the chimera, even in
the absence of BK (data not shown), we were not able
to perform two-dimensional phosphopeptide mapping of
the chimera, as successfully carried out for B2wt (Kalats-
kaya et al., 2004). The strong basal phosphorylation
observed in our experiment with B2eGFP may, therefore,
result in part from phosphorylation of the eGFP-domain
itself. Furthermore, it is conceivable that a specific phos-
phorylation pattern, generated during recycling of the
receptor, is necessary to finally direct an internalized
receptor to the degradation pathway and that this pattern
cannot be created in the presence of eGFP fused to the
C-terminus. Simaan et al. (2005) recently showed that
proper interaction of the bradykinin B2 receptor with b-
arrestin2 is important for recycling and resensitization
of the receptor after stimulation. Fusion of eGFP to the
receptor C-terminus might affect this interaction in a
manner that favors recycling over degradation. Of
course, other processes such as ubiquitination, that are
widely discussed for receptor internalization and down-
regulation (Haglund et al., 2003; Shenoy and Lefkowitz,
2005), may be also involved and could be hampered –
although not completely blocked – by the C-terminal
presence of eGFP.
Taken together, our results demonstrate that internali-
zation of B2wt is most likely required for its down-regu-
lation. However, while fusion of eGFP to the C-terminus
does not affect most of the features of the receptor, such
as receptor affinity shift or ligand-induced receptor inter-
nalization, it does strongly reduce receptor down-regu-
lation through promotion of the recycling of internalized
receptors over degradation. Therefore, data obtained in
recovery and localization experiments with eGFP-tagged
GPCRs should be interpreted with caution as to whether
the results also apply to the wild-type receptor. As the
presence of eGFP at the C-terminus results in uncoupling
of the processes of internalization and down-regulation,
the use of eGFP-fusion proteins might represent an
excellent tool to identify the determinants that are deci-
sive for recycling vs. down-regulation of an internalized
receptor through, e.g., overexpression of proteins that
are supposed to be involved in receptor down-regulation.
This information should eventually allow the generation
of compounds that therapeutically enhance or reduce the
action of endogenous hormones or exogenous drugs by
influencing the balance between recycling and degrada-
tion of the GPCRs that mediate their effects.
Materials and methods
Expression vector and expression system
For expression of B2wt, we used the sequence starting with the
third encoded methionine (Hess et al., 1992). For generation of
the B2eGFP chimera, the sequence for eGFP taken from the
pEGFP-C1 vector (Clontech, Heidelberg, Germany) was joined
to the C-terminus of B2wt using standard PCR technology with
a chimeric primer that included the start codon of eGFP and left
out the B2wt stop codon (Faussner et al., 2003). For stable con-
struct expression, the Flp-In system (Invitrogen, Karlsruhe, Ger-
many) was employed, whereby the vector containing the gene
of interest is inserted at a specific position into the genome of
a commercially available host cell line (Flp-In T-REx-293; Invi-
trogen) through the transient co-expression of a recombinase.
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All receptor coding sequences were preceded at the N-terminus
by a single hemagglutinin (HA)-tag (MGYPYDVPDYAGS), with
the last two amino acids (GS) of the tag generated by the inser-
tion of a BamHI site, and were cloned into the HindIII and the
XhoI sites of the pcDNA5/FRT vector. HEK 293 cells were trans-
fected using Fugene (Roche, Mannheim, Germany) according to
the manufacturer’s instructions and stable clones were selected
using 250 mg/ml hygromycin B. The cells were cultivated in
DMEM supplemented with 10% fetal calf serum and penicillin/
streptomycin. For monolayer experiments requiring rinsing of the
cells, poly-D-lysine-treated w0.01% in phosphate-buffered saline
(PBS)x multi-well plates were used.
Binding studies: determination of affinity (Kd) shift at
48C and at 378C
To compare the binding affinities of the constructs at 48C and
at 378C, receptor sequestration was inhibited by pretreatment
of cell monolayers in 48-well plates with 100 mM phenylarsine
oxide (PAO) for 5 min at 378C, as recently reported (Faussner et
al., 2004). Thereafter, cells were rinsed with PBS and incubated
with increasing concentrations of w3HxBK (0.01–30 nM) in incu-
bation buffer (40 mM PIPES, 109 m NaCl, 5 mM KCl, 0.1% glu-
cose, 0.05% BSA, 2 mM CaCl2, 1 mM MgCl2, pH 7.4, and the
protease inhibitors 2 mM bacitracin, 0.8 mM 1,10-phenanthroline,
and 100 mM captopril). After 30 min, the plates were placed on
ice and washed with PBS either immediately (Kd at 378C) or after
an additional incubation step for 90 min on ice (Kd at 48C). Sur-
face-bound w3HxBK was dissociated in both cases using an ice-
cold dissociation solution (0.2 M acetic acid/0.5 M NaCl, pH 2.7)
for 10 min and samples were then transferred to scintillation
vials. The radioactivity of all samples was then determined in a
b-counter after addition of scintillation fluid. Non-specific bind-
ing was measured in the presence of 5 mM unlabeled BK and
subtracted from total binding to obtain the specific values.
Internalization of w3HxBK
Cells seeded on 24-well plates were rinsed three times with PBS
and incubated with w3HxBK (-1.5 nM) in incubation buffer for
90 min on ice to reach equilibrium binding. Thereafter, w3HxBK
internalization was initiated by placing the plates in a water bath
at 378C. At the times indicated, the internalization process was
stopped by putting the plates back on ice and washing them
with ice-cold PBS. Surface-bound w3HxBK was separated by
treating the monolayers with ice-cold dissociation solution for
10 min on ice and was then quantitatively transferred to a scin-
tillation vial. The remaining monolayer containing the internalized
w3HxBK was lysed with 0.3 M NaOH and also transferred to a
scintillation vial. The radioactivity of both samples was deter-
mined in a b-counter after addition of scintillation fluid. Non-
receptor-mediated w3HxBK internalization and surface binding
were measured in the presence of 5 mM unlabeled BK and sub-
tracted from total binding to calculate the specific values.
Receptor phosphorylation
Confluent cells on six-well plates were washed twice with phos-
phate-free DMEM, incubated for 3 h at 378C in the same medi-
um, and labeled with 0.2 mCi/ml w32Px orthophosphate for
10–12 h. After exposure to 1 mM BK for 5 min at 378C, mono-
layers were solubilized in 0.5 ml of RIPA buffer (50 mM Tris-HCl,
150 mM NaCl, 1% Nonidet P-40, 0.5% sodium deoxycholate,
0.1% SDS, 2 mM EDTA, pH 7.5) supplemented with 0.5 mM
Pefabloc SC (Roche) and 10 mM each of 1,10-phenanthroline,
aprotinin, leupeptin, and pepstatin A and phosphatase inhibitors
(25 mM NaF, 1 mM sodium orthovanadate, 0.3 mM okadaic acid)
for 1 h at 48C with gentle rocking. The lysate was centrifuged at
6000 g for 20 min at 48C. The supernatant was incubated with
15 ml of anti-HA affinity matrix (Roche) for 4 h at 48C. The mix-
ture was then washed twice with RIPA buffer and once with
distilled water. Electrophoresis on a 10% SDS polyacrylamide
gel and electroblotting were carried out as previously described
(Kalatskaya et al., 2004). The proteins of interest were identified
by autoradiography.
Determination of BK stability in culture medium
To determine the stability of BK in media with differently treated
fetal calf serum (with and without incubation for 2 h in a water
bath at 608C), BK was added to cell monolayers (48-well plates)
in these media (500 ml) to a final concentration of 10 mM and
incubated at 378C for the times indicated. Thereafter, 10 ml of
the respective medium was added to 150 ml of 2 nM w3HxBK in
incubation buffer and binding to cells expressing B2wt in 48-well
plates was determined as described above at 48C. The reduction
in w3HxBK binding was expressed as a percentage of the binding
measured in B2wt control cells that received 10 ml of the media
without addition of BK.
Receptor down-regulation and recovery
For down-regulation experiments, confluent cell monolayers in
48-well plates were incubated with 10 mM BK in 500 ml of medi-
um containing 10% fetal calf serum that was pretreated for 2 h
at 608C to reduce its proteolytic activity (inactivated serum). At
the times indicated, both bound and free unlabeled BK were
removed by treating the cell monolayers immediately with ice-
cold dissociation solution for 10 min and rinsing them with PBS.
Alternatively, for recovery experiments the cells were first
washed with 1 ml of cell culture medium at 378C containing fresh
(to promote degradation of residual BK) fetal calf serum, incu-
bated in another 1 ml of medium for 1 h at 378C and then treated
with the dissociation solution. To measure the remaining surface
binding, all cells were incubated with approximately 2 nM w3HxBK
in incubation buffer on ice. After 90 min, free w3HxBK was
removed by rinsing the cells with PBS and surface-bound
w3HxBK was determined after dissociation with ice-cold disso-
ciation solution as described above. Non-specific binding was
measured in the presence of 5 mM unlabeled BK.
Determination of total inositol phosphate (IP)
release
Confluent monolayers in 12-well plates were incubated over-
night with 0.5 ml of medium containing 10% inactivated fetal
calf serum and 0.5 mCi w3Hxinositol. The cells were washed with
PBS and preincubated on ice in incubation buffer supplemented
with 50 mM LiCl with or without the addition of BK (10-11–10-5
M). After 90 min the accumulation of IP was started by placing
the cells in a water bath at 378C. The stimulation was terminated
after 30 min by exchanging the buffer for 0.75 ml of ice-cold
20 mM formic acid solution. Total IPs were then determined
using AG 1-X8 anion exchange columns as previously described
(Kalatskaya et al., 2004).
Protein determination
Total protein was quantified with the Micro BCA Protein assay
reagent kit from Pierce (Rockford, IL, USA) using bovine serum
albumin as standard.
Data analysis
All data analysis was performed using GraphPad Prism for
Macintosh, Version 3.0a (GraphPad Software, Inc., San Diego,
CA, USA).
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